Rapid advancements in technology are spurring disruption in nearly every industry, and the biotech and pharmaceutical markets are no exception. From biosensors and 3D bioprinting to gene editing and tissue engineering, there is no doubt that significant evolution is...

One of the biggest challenges pharmaceutical companies face is getting new medications approved and in the hands of patients as planned. Many times, delays begin in the development phase and can last for years with variant after variant falling short of expectations...

The speed at which a clinical trial is completed can mean the difference between ‘first to market’ and a ‘me too’ product for pharmaceutical companies, and the resulting financial implications can be astronomical. Numerous requirements can make it difficult to enlist...

It’s no secret, many of the volunteers who decline the opportunity to be part of a clinical trial do so because of the distance to the research site location. They can’t see themselves driving 1-2 hours to the site and then driving 1-2 hours back home every week for...